Highlights and Quick Summary
- Non-current Liabilities (Other) for the quarter ending November 30, 2022 was $5.88 Million (a -25.13% decrease compared to previous quarter)
- Year-over-year quarterly Non-current Liabilities (Other) decreased by -63.83%
- Annual Non-current Liabilities (Other) for 2022 was $7.86 Million (a -79.13% decrease from previous year)
- Annual Non-current Liabilities (Other) for 2021 was $37.6 Million (a 1676.34% increase from previous year)
- Annual Non-current Liabilities (Other) for 2020 was $2.12 Million (a 151.44% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-current Liabilities (Other) of Organigram Holdings Inc.
Most recent Non-current Liabilities (Other)of OGI including historical data for past 10 years.Interactive Chart of Non-current Liabilities (Other) of Organigram Holdings Inc.
Organigram Holdings Inc. Non-current Liabilities (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $5.88 | $7.86 | $10.47 | $16.26 | $7.86 |
2021 | $26.31 | $37.63 | $43.03 | $41.52 | $37.63 |
2020 | $16.93 | $2.12 | $2.2 | $1.76 | $2.12 |
2019 | $1.97 | $0.84 | $1.48 | $1.21 | $0.84 |
2018 | – | – | – | $0.74 | – |
2017 | – | – | – | – | $0.0 |
2016 | – | – | – | – | $0.0 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic